PACS — PACS Group, Inc. stock price, charts and financials

NYSE·Healthcare·Medical - Care Facilities·USA

Latest market price

48.58

+0.14+0.29%

Overview Short InterestFilings

PACSQT87PACS Group, Inc.·NYSE

Overview Short InterestFilings

48.58+0.29%

Loading chart...

Signal & projected range

Earnings big beat — drift (PEAD)Historical pattern — not a prediction

Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)

Horizon

Unlock the projected rangeSee where this setup landed historically — with Premium.

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Premium shows the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands ofhistorical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →

CHE-0.31%$550.98 UHS-0.48%$172.71 ENSG+0.46%$183.81 DVA-0.70%$182.48 EHC-0.24%$124.93 FMS+0.33%$24.35 CON-2.01%$33.38 LFST+12.18%$12.16

Snapshot

Index	-	P/E	28.49	EPS (ttm)	1.70	Insider Own	-	Shs Outstand	158.34M	Perf Week	5.28%

Market Cap	7.67B	Forward P/E	18.82	EPS next Y	2.57	Insider Trans	-0.66%	Shs Float	47.80M	Perf Month	10.54%

Enterprise Value	10.76B	PEG	0.28	EPS next Q	-	Inst Own	-	Short Float	2.86%	Perf Quarter	44.04%

Income	269.21M	P/S	1.38	EPS this Y	56.57%	Inst Trans	-	Short Ratio	4.91	Perf Half Y	31.38%

Sales	5.55B	P/B	6.90	EPS next Y	8.86%	ROA	4.76%	Short Interest	4.53M	Perf YTD	26.18%

Book/sh	-	P/C	9.46	EPS next 5Y	8.94%	ROE	27.15%	52W High	49.63 -2.12%	Perf Year	338.37%

Cash/sh	-	P/FCF	14.56	EPS past 3/5Y	6.85% -	ROIC	6.06%	52W Low	7.52 545.87%	Perf 3Y	-

Dividend Est.	-	EV/EBITDA	22.40	Sales past 3/5Y	29.74% -	Gross Margin	19.68%	Volatility	7.83% 5.14%	Perf 5Y	-

Dividend TTM	-	EV/Sales	1.94	EPS Y/Y TTM	297.37%	Oper. Margin	7.39%	ATR (14)	2.50	Perf 10Y	-

Dividend Ex-Date	-	Quick Ratio	0.91	Sales Y/Y TTM	32.81%	Profit Margin	4.85%	RSI (14)	66.28	Recom	2.13

Dividend Gr. 3/5Y	-	Current Ratio	0.91	EPS Q/Q	19.05%	SMA20	5.81%	Beta	0.40	Target Price	53.00

Payout	0.00%	Debt/Eq	2.93	Sales Q/Q	11.20%	SMA50	16.39%	Rel Volume	0.97	Prev Close	48.44

Employees	47,455	LT Debt/Eq	3.58	Earnings	Nov 25	SMA200	40.06%	Avg Volume	997.19K	Price	48.58

IPO Date	Apr 11, 2024	Option/Short	Yes / Yes	EPS/Sales Surpr.	25.06% 4.13%	Net Debt/EBITDA	6.43	Volume	968,193	Change	0.29%

Analyst Ratings

Date	Action	Analyst	Rating	Target
Aug-06-26	Reiterated	UBS	Buy	$57 → $60
Jul-08-26	Reiterated	UBS	Buy	$42 → $57
May-18-26	Reiterated	Truist Securities	Buy	$40 → $52
May-13-26	Reiterated	Oppenheimer	Outperform	$40 → $48
Feb-27-26	Reiterated	RBC Capital	Outperform	$47 → $52
Dec-19-25	Reiterated	RBC Capital	Outperform	$33 → $47
Dec-18-25	Resumed	UBS	Buy	$42
Dec-12-25	Reiterated	Truist Financial	Buy	$32 → $40
Nov-20-25	Reiterated	RBC Capital	Outperform	$30 → $33
Dec-17-24	Downgrade	JP Morgan	Overweight → Neutral

Latest News

Aug-08-26

Aug-08-2608:05PM

PACS Group Q2 Earnings Call Highlightsmarketbeat.com

Aug-06-26

Aug-06-2603:35PM

UBS Maintains Buy on PACS Group, Raises Price Target to $60Benzinga

Aug-05-26

Aug-05-2603:50PM

PACS Group, Inc. (PACS) Q2 2026 Earnings Call Transcriptseekingalpha.com

Aug-04-26

Aug-04-2608:02PM

PACS Group, Inc. (PACS) Surpasses Q2 Earnings and Revenue Estimateszacks.com

04:30PM

PACS Group, Inc. Reports Second Quarter 2026 Resultsbusinesswire.com

Jul-30-26

Jul-30-2612:41PM

PACS or ALHC: Which Is the Better Value Stock Right Now?zacks.com

Jul-28-26

Jul-28-2604:30PM

PACS Group Schedules Second Quarter 2026 Earnings Release and Conference Callbusinesswire.com

Jul-23-26

Jul-23-2607:00AM

Kaskela Law Firm Announces Investigation of PACS Group, Inc. (PACS) and Encourages Long-Term PACS Shareholders to Contact the Firmbusinesswire.com

Jul-17-26

Jul-17-2601:35PM

4 Health Care Stocks Whale Activity In Today’s SessionBenzinga

Jul-14-26

Jul-14-2601:30PM

Top 10 Stocks For H2 2026SeekingAlpha

12:40PM

PACS or ALHC: Which Is the Better Value Stock Right Now?zacks.com

10:05AM

NYSE: PACS ALERT: Investors in shares of PACS Group, Inc. shares should contact the Shareholders Foundation in connection with Lawsuitprnewswire.com

Jul-08-26

Jul-08-2602:47PM

UBS Maintains Buy on PACS Group, Raises Price Target to $57Benzinga

Jun-30-26

Jun-30-2610:24PM

PACS Group (PACS) Price Target Increased by 12.27% to 51.20Fintel

Jun-29-26

Jun-29-2604:05PM

PACS Group to Acquire Operations of 34 Facilities Across Texas, Montana, New Mexico, North Dakota, South Dakota, and Utahbusinesswire.com

Company

PACS Group, Inc. operates as a holding company, primarily focused on delivering post-acute healthcare services. This encompasses operating various facilities, providing skilled professionals, and offering essential ancillary support. The company further specializes in providing a spectrum of senior living options, encompassing dedicated senior care, assisted living, and independent living residences in select communities. Founded in 2013 by Jason Murray and Mark Hancock, its corporate headquarters are located in Farmington, Utah.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements

DataTimeframe

Line Item (USD, M)	TTM —	FY 2025 12/31/2025	FY 2024 12/31/2024	FY 2023 12/31/2023	FY 2022 12/31/2022	FY 2021 12/31/2021
Total Revenue	5,551	5,289	4,090	—	—	—
Cost of Goods Sold Incl. D&A	4,458	4,130	3,297	—	—	—
Gross Profit	1,092	1,159	793	—	—	—
Selling, General and Administrative Excl. Other	442	415	344	—	—	—
Research and Development	0	0	0	—	—	—
Other Operating Expense	240	435	326	—	—	—
Operating Income	410	310	123	—	—	—
Interest Expense	30	28	44	—	—	—
Unusual Expense	—	—	—	—	—	—
Non-Operating Income (Expense)	3	3	23	—	—	—
Net Income Before Taxes	383	284	102	—	—	—
Income Taxes	113	93	46	—	—	—
Consolidated Net Income	269	192	56	—	—	—
Net Income From Continuing Operations	269	192	55	—	—	—
Net Income	269	192	56	—	—	—
EPS (Recurring)	1.70	1.23	0.38	—	—	—
EPS (Basic, Before Extraordinaries)	1.70	1.23	0.38	—	—	—
EPS (Diluted)	1.67	1.22	0.38	—	—	—
EBITDA	480	366	187	—	—	—
Other After Tax Adjustments	—	—	—	—	—	—
Stock Option Compensation Expense	—	—	—	—	—	—
Price To Earnings Ratio	29.09	31.47	34.50	—	—	—
Price To Sales Ratio	1.38	1.13	0.47	—	—	—
Gross Margin	19.67	21.91	19.39	—	—	—
Operating Margin	7.39	5.86	3.01	—	—	—
Net Margin	4.85	3.63	1.37	—	—	—
Shares Outstanding	158	156	147	—	—	—
Market Capitalization	7,676	5,989	1,927	—	—	—
Operating Lease Expense	—	—	—	—	—	—

Unlock full historical data

See years of past statements with Premium.

Insider Trading Volume

Insider Trading

Insider	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Jergensen Joshua	President & COO	Jul 15 '26	Sale	45.02	40,000	1,800,718	2,576,320	Jul 16
Hancock Mark	director, 10 percent owner:	Jul 15 '26	Sale	45.05	3,332	150,115	53,906,884	Jul 16
Hancock Mark	director, 10 percent owner:	Jul 14 '26	Sale	45.03	10,296	463,680	53,910,216	Jul 16
Hancock Mark	director, 10 percent owner:	Jul 09 '26	Sale	45.06	4,966	223,781	53,920,512	Jul 10
Hancock Mark	director, 10 percent owner:	Jul 08 '26	Sale	45.07	20,338	916,611	53,925,478	Jul 10
Hancock Mark	director, 10 percent owner:	Jul 06 '26	Sale	45.33	142,163	6,444,860	53,945,816	Jul 06
Lewis Michelle Renee	Chief Accounting Officer	Jul 06 '26	Sale	45.04	4,137	186,333	355,338	Jul 06
Hancock Mark	director, 10 percent owner:	Jul 02 '26	Sale	45.01	12,825	577,290	54,087,979	Jul 06
Lewis Michelle Renee	Chief Accounting Officer	Jul 02 '26	Sale	45.03	6,663	300,032	359,475	Jul 06
Lewis Michelle Renee	Chief Accounting Officer	Jul 01 '26	Sale	45.01	4,200	189,059	366,138	Jul 06
Hancock Mark	director, 10 percent owner:	Jul 01 '26	Sale	45.02	6,080	273,716	54,100,804	Jul 06
Hancock Mark	Co Fndr; Exec V Chair	Jun 26 '26	Sale	40.50	61,931	2,508,085	54,102,597	Jun 26
Lewis Michelle Renee	Chief Accounting Officer	Jun 25 '26	Sale	40.01	15,000	600,179	370,338	Jun 26
Hancock Mark	Co Fndr; Exec V Chair	Jun 25 '26	Sale	40.33	138,069	5,567,701	54,164,528	Jun 26
Hancock Mark	Co Fndr; Exec V Chair	Jun 17 '26	Sale	35.31	63,680	2,248,415	54,302,597	Jun 22

open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR

QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.